Bush says the problem was that patients weren't getting enough of a B vitamin, and that no such safety issues have showed up in the current trial.
FORBES: Magazine Article
Vitamin manufacturers are to invited to submit evidence of the efficacy and safety of their high-dose products.
BBC: Clampdown on 'high-dose' vitamins
应用推荐
模块上移
模块下移
不移动